PPSIENCT07917325
Metabolic Profiling Among Patients Suspected of Infective Endocarditis - PPSIE Comparing Metabolomes of Bloodstream Infections Versus Infective Endocarditis
StatusNot Yet Recruiting
PhaseNot applicable
SponsorUniversity Hospital, Angers
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Metabolomic signature
Timeframe: Day 1 and Day 5 after enrollement
Secondary (4)
Identify potential biomarkers (BM) that can distinguish patients with BaSAC from those with EI.
Describe changes in the metabolic signature in patients with endocarditis 5 days and 3 months after enrollment and correlate these changes with the diagnosis of IE.
Diagnostic performance of the identified biomarker(s) in a subset of patients with "possible" endocarditis according to the Duke classification revised by the ISCVID in 2023.
Conduct a sensitivity analysis on the correct classification of patients as "definite IE" according to the Duke classification revised by the ISCVID in 2023 by comparing it with the Duke and Li classification.
Arms and interventions
Patients included in the studyExperimental
Procedures: Blood sample
Sites
3 sites in 1 country